SCOPE FLUIDICS SA ZY-10 (S84) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SCOPE FLUIDICS SA ZY-10 (S84) has a cash flow conversion efficiency ratio of -0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.68 Million ≈ $-13.65 Million USD) by net assets (€162.43 Million ≈ $189.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SCOPE FLUIDICS SA ZY-10 (S84) market capitalisation for the company's overall valuation and market capitalisation.
SCOPE FLUIDICS SA ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how SCOPE FLUIDICS SA ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SCOPE FLUIDICS SA ZY-10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SCOPE FLUIDICS SA ZY-10 ranked by their cash flow conversion efficiency. Explore SCOPE FLUIDICS SA ZY-10 (S84) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tsang Yow Industrial Co Ltd
TW:1568
|
0.033x |
|
Tainergy Tech Co Ltd
TW:4934
|
-0.035x |
|
Negri Sembilan Oil Palms Bhd
KLSE:2038
|
0.007x |
|
Lakeshore Acquisition III Corp. Ordinary Shares
NASDAQ:LCCC
|
-0.005x |
|
Papoutsanis S.A
AT:PAP
|
0.086x |
|
Yuhwa Sec
KO:003460
|
0.061x |
|
Shinsegae Food
KO:031440
|
-0.062x |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
4.726x |
Annual Cash Flow Conversion Efficiency for SCOPE FLUIDICS SA ZY-10 (2021–2025)
The table below shows the annual cash flow conversion efficiency of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025. View S84 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €162.43 Million ≈ $189.90 Million |
€-46.11 Million ≈ $-53.91 Million |
-0.284x | -65.50% |
| 2024-12-31 | €146.35 Million ≈ $171.10 Million |
€-25.10 Million ≈ $-29.35 Million |
-0.172x | +27.15% |
| 2023-12-31 | €80.93 Million ≈ $94.62 Million |
€-19.06 Million ≈ $-22.28 Million |
-0.235x | -178.45% |
| 2022-12-31 | €332.97 Million ≈ $389.28 Million |
€-28.16 Million ≈ $-32.92 Million |
-0.085x | +97.33% |
| 2021-12-31 | €6.74 Million ≈ $7.88 Million |
€-21.37 Million ≈ $-24.98 Million |
-3.171x | -- |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.